Analysis of effector and regulatory immune reactivity to nickel

Clinical and Experimental Allergy

Volumn 34, Issue 9, 2004, Pages 1458-1466

  Rustemeyer, T ^a   Von Blomberg, E B M ^a   Van Hoogstraten, I M W ^a   Bruynzeel, D P ^a   Scheper, R J ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Contact allergy; In vitro detection; Lymphocyte proliferation test; Nickel; Patch test; Tolerance

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; NICKEL; TRANSFORMING GROWTH FACTOR BETA;

ACCURACY; ALLERGIC REACTION; ALLERGY; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL PROLIFERATION; CYTOKINE PRODUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREACTIVITY; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE; MAJOR CLINICAL STUDY; OUTPATIENT; PATCH TEST; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; ALLERGENS; CELLS, CULTURED; DERMATITIS, ALLERGIC CONTACT; FEMALE; HUMANS; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; INTERLEUKIN-5; INTERLEUKIN-7; IRRITANTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NICKEL; PATCH TESTS; T-LYMPHOCYTES;

EID: 4544377945     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02045.x     Document Type: Article

References (51)

1. Grabbe S, Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998; 19:37-44.
2. Rustemeyer T, van Hoogstraten IMW, Scheper RJ, von Blomberg BME. Mechanisms in allergic contact dermatitis. In: Rycroft RJG, Menné T, Frosch PJ, eds. Textbook of contact dermatitis, 3rd edn. Berlin, Heidelberg, New York: Springer Verlag, 2001.
3. Rycroft RJG, Menné T, Frosch PJ, eds. Textbook of contact dermatitis, 3rd edn. Berlin Heidelberg New York: Springer Verlag, 2001.
4. Schafer T, Bohler E, Ruhdorfer S et al. Epidemiology of contact allergy in adults. Allergy 2001; 56:1192-6.
5. Romaguera C, Grimalt F, Vilaplana J. Contact dermatitis from nickel: an investigation of its source. Contact Dermal 1988; 19: 52-7.
6. Jadassohn J. Zur Kenntnis der Arzeiexantheme. Arch Dermatol Forsch 1896; 34:103.
7. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocyts with distinct homing potentials and effector functions. Nature 1999; 401:708-12.
8. Gerberick GF, Robinson MK. A skin sensitization risk assessment approach for evaluation of new ingredients and products. Am J Contact Dermat 2000; 11:65-73.
9. Scheper RJ, Oort J. Some in vitro experimental methods in allergic contact dermatitis. Arch Belg Derm 1973; 28:59-72.
10. von Blomberg BME, Bruynzeel DP, Scheper RJ Advances in mechanisms of allergic contact dermatitis: in vitro and in vivo research. In: Marzulli FN, Maibach HI, eds. Dermatotoxicology, 4th edn. New York: Hemisphere Publishing Corporation, 1991; 255-362.
11. De Gruijl TD, Moore JJ, de Vries E, von Blomberg-van der Flier BM, Fonk JC, Scheper RJ. Augmentation of antigen-specific lymphoproliferative responses in vitro by biological response modifiers. Clin Exp Immunol 1994; 96:535-40.
12. Kapsenberg ML, Wierenga EA, Stiekema FE, Tiggelman AM, Bos JD. Th1 lymphokine production profiles of nickel-specific CD4+T-lymphocyte clones from nickel contact allergic and non-allergic individuals. J Invest Dermatol 1992; 98:59-63.
13. Sinigaglia F, Scheidegger D, Garotta G, Scheper R, Pletscher M, Lanzavecchia A. Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol 1985; 135:3929-32.
14. Probst P, Kuntzlin D, Fleischer B. TH2-type infiltrating T cells in nickel-induced contact dermatitis. Cell Immunol 1995; 165:134-40.
15. + T cells. J Invest Dermatol 1998; 111:621-8.
16. Borg L, Christensen JM, Kristiansen J, Nielsen NH, Menne T, Poulsen LK. Nickel-induced cytokine production from mononuclear cells in nickel-sensitive individuals and controls. Cytokine profiles in nickel-sensitive individuals with nickel allergy-related hand eczema before and after nickel challenge. Arch Dermatol Res 2000; 292:285-91.
17. Werfel T, Hentschel M, Kapp A, Renz H. Dichotomy of blood-and skin-derived IL-4-producing allergen-specific T cells and restricted V beta repertoire in nickel-mediated contact dermatitis. J Immunol 1997; 158:2500-5.
18. + T cells. Annu Rev Immunol 1994; 12:635-73.
19. Carter LL, Zhang X, Dubey C, Rogers P, Tsui L, Swain SL. Regulation of T cell subsets from naive to memory. J Immunotherapy 1998; 21:181-7.
20. Romagnani S. Th1/Th2 cells. Inflamm Bowel Dis 1999; 5:285-94.
21. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-18.
22. Weber C, Springer TA. Interaction of very late antigen-4 with VCAM-1 supports transendothelial chemotaxis of monocytes by facilitating lateral migration. J Immunol 1998; 161:6825-34.
23. Shimada H, Eguchi K, Ueki Y et al. Interleukin 4 increases human synovial cell expression of VCAM-1 and T cell binding. Ann Rheum Dis 1994; 53:601-7.
24. Armitage RJ, Namen AE, Sassenfeld HM, Grabstein KH. Regulation of human T cell proliferation by IL-7. J Immunol 1990; 144:938-41.
25. Welch PA, Namen E, Goodwin RG, Armitage R, Cooper MD. Human IL-7: a novel T cell growth factor. J Immunol 1989; 143:3562-7.
26. Lotze MT, Zeh HJ, Elder EM et al. Use of T-cell growth factors (interleukin 2, 4, 7, 10 and 12) in the evaluation of T-cell reactivity to melanoma. J Immunother 1992; 21:2977-85.
27. Page TH, Willcocks JL, Taylor-Fishwick DA, Foxwell BM. Characterization of a novel affinity human IL-7 receptor. Expression on T cells and association with IL-7 driven proliferation. J Immunol 1993; 51:4753-63.
28. Mehrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995; 154:5093-102.
29. Grabstein KH, Namen AE, Shanebeck K, Voice RF, Reed SG, Widmer MB. Regulation of T cell proliferation by IL-7. J Immunol 1990; 144:3015-20.
30. Foxwell BM, Taylor-Fishwick DA, Simon JL, Page TH, Londei M. Activation induced changes in expression and structure of the IL-7 receptor an human T cells. Int Immunol 1992; 4:277-82.
31. Gringhuis SI, de Leij LF, Veschuren EW, Borger P, Vellenga E. Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transscriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 1997; 90:2690-700.
32. Trinchieri G, Peritt D, Gerosa F. Acute induction and priming for cytokine production in lymphocytes. Cytokine Growth Factor Rev 1996; 7:123-32.
33. Stern AS, Magram J, Presky DH. Interleukin-12 an integral cytokine in the immune response. Life Sci 1996; 58:639-54.
34. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13:251-76.
35. Yssel H, Schneider PV, Lanier LL. Interleukin-7 specifically induces the B//BB1 antigen on human cord blood and peripheral blood T cells and T cell clones. Int Immunol 1993; 5:753-9.
36. Dennig D, O'Reilly RJ. IL-7 increases surface expression of B7/BB1 on pre-B cells and an associated increase in their costimulatory effects on T cell proliferation. Cell Immunol 1994; 153:227-38.
37. van Hoogstraten IMW, Andersen KE, von Blomberg BME et al. Reduced frequency of nickel allergy upon oral nickel contact at an early age. Clin Exp Immunol 1991; 85:441-5.
38. Jonker MJ, Bruynzeel DP. The outcome of an additional patch-test reading on days 6 or 7. Contact Dermat 2000; 42:330-5.
39. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, eds. Current protocols in immunology, 1st edn. New York: Greene & Wiley, 2001; 7.1-7.8.
40. Kestler HA. ROC with confidence - a Perl program for receiver operator characteristic curves. Comput Methods Programs Biomed 2001; 64:133-6.
41. Brasch J, Henseler T, Aberer W et al. Reproducibility of patch tests A multicenter study of synchronous left-versus right-sided patch tests by the German Contact Dermatitis Research Group. J Am Acad Dermatol 1994; 31:584-91.
42. Gollhausen R, Przybilla B, Ring J. Reproducibility of patch tests. J Am Acad Dermatol 1989; 21:1196-202.
43. Rietschel RL. Reproducibility of patch-test results. Lancet 1996; 347:1202.
44. Sachs B, Erdmann S, Malte Baron J, Neis M, al Masaoudi T, Merk HF. Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization. Clin Exp Allergy 2002; 32:736-44.
45. Lindemann M, Bohmer J, Zabel M, Grosse-Wilde H. ELISpot: a new tool for the detection of nickel sensitization. Clin Exp Allergy 2003; 33:992-8.
46. Janeway C. Immunobiology. 5th edn. New York: Garland Publication, 2001.
47. Perez VL, Lederer JA, Lichtman AH, Abbas AK. Stability of Th1 and Th2 populations. Int Immunol 1995; 7:869-75.
48. Kitagaki H, Kimishima M, Teraki Y et al. Distinct in vivo and in vitro cytokine profiles of draining lymph node cells in acute and chronic phases of contact hypersensitivity: importance of a type 2 cytokine-rich cutaneous milieu for the development of an early-type response in the chronic phase. J Immunol 1999; 163:1265-73.
49. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J Immunol 1997; 159:2484-91.
50. Sebastiani S, Albanesi C, Nasorri F, Girolomoni G, Cavani A. Nickel-specific CD4(+) and CD8(+) T cells display distinct migratory responses to chemokines produced during allergic contact dermatitis. J Invest Dermatol 2002; 118:1052-8.
51. Lindsten R, Kurol J. Orthodontic appliances in relation to nickel hypersensitivity. J Orofac Orthop 1997; 58:100-8.